U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H15FN6OS
Molecular Weight 358.393
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FEZOLINETANT

SMILES

C[C@H]1N(CCN2C1=NN=C2C3=NC(C)=NS3)C(=O)C4=CC=C(F)C=C4

InChI

InChIKey=PPSNFPASKFYPMN-SECBINFHSA-N
InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1

HIDE SMILES / InChI
Fezolinetant (ESN-364) is an antagonist of the neurokinin-3 receptor. It suppresses the hypothalamic-pituitary-gonadal axis. Ogeda is developing fezolinetant for the treatment of hot flashes (vasomotor symptoms) in postmenopausal women.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P29371
Gene ID: 6870.0
Gene Symbol: TACR3
Target Organism: Homo sapiens (Human)
7.6 null [pKi]
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Phase 2 study for the treatment of hot flashes (vasomotor symptoms) in postmenopausal women. The dose of ESN364 varies across 7 treatment groups, with groups receiving once a day or twice a day blinded study drug. Doses range from 30 mg to 180 mg total daily dosing for 12 weeks.
Route of Administration: Oral
Name Type Language
FEZOLINETANT
INN   WHO-DD  
USAN   INN  
Official Name English
AS-3472693-00
Code English
(4-FLUOROPHENYL)((8R)-8-METHYL-3-(3-METHYL-1,2,4- THIADIAZOL-5-YL)-5,6-DIHYDRO-1,2,4-TRIAZOLO(4,3-A)PYRAZIN- 7(8H)-YL)METHANONE
Systematic Name English
FEZOLINETANT [USAN]
Common Name English
METHANONE, ((8R)-5,6-DIHYDRO-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)(4-FLUOROPHENYL)-
Systematic Name English
VEOZAH
Brand Name English
fezolinetant [INN]
Common Name English
ES-256364
Code English
A-2693
Code English
(4-FLUOROPHENYL)((8R)-5,6-DIHYDRO-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)METHANONE
Systematic Name English
A2693
Code English
((8R)-5,6-DIHYDRO-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)(4-FLUOROPHENYL)METHANONE
Systematic Name English
AS3472693-00
Code English
ESN-364
Code English
Fezolinetant [WHO-DD]
Common Name English
ESN364
Code English
Code System Code Type Description
USAN
HI-226
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
NCI_THESAURUS
C171845
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
DRUG BANK
DB15669
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
WIKIPEDIA
FEZOLINETANT
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
PUBCHEM
117604931
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
EPA CompTox
DTXSID601103615
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
SMS_ID
100000174631
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
CAS
1629229-37-3
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
FDA UNII
83VNE45KXX
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY
INN
10205
Created by admin on Sat Dec 16 02:53:17 UTC 2023 , Edited by admin on Sat Dec 16 02:53:17 UTC 2023
PRIMARY